Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing
Reexamination Certificate
2008-04-22
2008-04-22
Belyavskyi, Michail (Department: 1644)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
C424S093700
Reexamination Certificate
active
10823263
ABSTRACT:
A method of creating tolerance to transplanted cells, tissue, or organs without the need for continuous immunosuppression. A tolerizing dose of a cell or tissue within a membrane structure is implanted into a patient. Once the patient becomes tolerant to the cell or tissue, a tissue or organ is implanted which will no longer be recognized as foreign matter. The method makes animal organs practical for human use, prevents autoimmune destruction as well as immune rejection. It has applications in treatment and prevention of many mammalian diseases.
REFERENCES:
patent: 4298002 (1981-11-01), Ronel et al.
patent: 4353888 (1982-10-01), Sefton
patent: 4378016 (1983-03-01), Loeb
patent: 4673566 (1987-06-01), Goosen et al.
patent: 4689293 (1987-08-01), Goosen et al.
patent: 4696286 (1987-09-01), Cochrum
patent: 4806355 (1989-02-01), Goosen et al.
patent: 4892538 (1990-01-01), Aebischer et al.
patent: 4902295 (1990-02-01), Walthall et al.
patent: 4997443 (1991-03-01), Walthall et al.
patent: 5182111 (1993-01-01), Aebischer et al.
patent: 5262055 (1993-11-01), Bae et al.
patent: 5290684 (1994-03-01), Kelly
patent: 5425764 (1995-06-01), Fournier et al.
patent: 5529914 (1996-06-01), Hubbell et al.
patent: 5629194 (1997-05-01), Dinsmore
patent: 6703017 (2004-03-01), Peck et al.
patent: A1 2034641 (1992-05-01), None
patent: A2 0147939 (1985-07-01), None
patent: 0 536 807 (1987-04-01), None
patent: WO 92/19195 (1992-12-01), None
patent: WO 95/03062 (1995-02-01), None
Roep et al ., Nature Reviews, 2004, v.4, pp. 989-997.
Mestas et al ., J. of Immunology, 2004, 172, pp. 2731-2738.
Teuveson et al., Immun. Review 1993, N136, pp. 101-107.
Feldman et al Transplant. Proc. 1998, 30, 4126-4127.
Posselt et al Diabetes, 1992, v.41, pp. 771-775.
Bingley, P.J. et al. (1994) “Combined analysis of autoantibodies, improves production of IDDM in islet cell antibody-positive relatives” Diabetes 43:1304(7).
Bonifacio, E. et al. (1995) “Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity” Diabetologia 38:816-822.
Christie, M.R. et al. (1994) “Antibodies is islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity” Diabetes 43:1254(6).
Lee, H.C. et al. (1995) “Relationships among 64k autoantibodies, pancreatic beta-cell function, HLA-DR antigens and HLA-DQ genes in patients with insulin-dependent diabetes mellitus in Korea” Korean J. Intem Med. (Abstract only).
Tuomilehto, J. et al. (1994) “Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease” Lancet 343:1383-1385.
Zimmet, P.Z. et al. (1994) “Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency” Diabetic Medicine 11:299-303.
Zimmet, P.Z. et al. (1994) “Autoantibodies to glutamic acid decarboxylase and insulin in islet cell antibody positive presymptomatic type 1 diabetes mellitus: frequency and segregation by age and gender” Diabetic Medicine 11:868-871.
Atkinson M.A. et al. (1999) “The NOD mouse model of type 1 diabetes: as good as it gets?” Nature Medicine 5:601-604.
Belyavskyi Michail
Knobbe Martens Olson & Bear LLP
LandOfFree
Method of treatment of diabetes through induction of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treatment of diabetes through induction of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment of diabetes through induction of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3943168